SINOVENT
Founded in 2016, Sinovent is a global biopharmaceutical company focused on innovation. Sinovent is centered around global standard excellence through its advanced biotechnology platform, decades of management experience, as well as financial support. Sinovent uniquely combines its expertise in science, management and finance, to develop and promote advanced treatment methods to solve worldwide healthcare problems. Currently, the company has 12 products in development, primarily in oncology, auto-immune diseases, and infectious diseases.
SINOVENT
Industry:
Biotechnology Life Science
Founded:
2017-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.sinovent.com.cn
Total Employee:
11+
Status:
Active
Contact:
+0512-88869230
Total Funding:
144.66 M USD
Technology used in webpage:
Domain Not Resolving Euro Pound Sterling Japanese Yen Baidu Maps
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Cerevance
Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Yidao Biotechnology
Yidao Biotechnology research and develops vaccines and biomedical products.
Current Advisors List
Founder
Investors List
CCB International
CCB International investment in Series C - Sinovent
Wen's Investment
Wen's Investment investment in Series C - Sinovent
Jiuyou Capital
Jiuyou Capital investment in Series C - Sinovent
CICC Qide
CICC Qide investment in Series C - Sinovent
Oceanpine Capital
Oceanpine Capital investment in Series C - Sinovent
Loyal Valley Capital
Loyal Valley Capital investment in Series C - Sinovent
Huaxu Investment
Huaxu Investment investment in Series C - Sinovent
Loyal Valley Capital
Loyal Valley Capital investment in Series A - Sinovent
More informations about "Sinovent"
Sinovent - Crunchbase Company Profile & Funding
Founded in 2016, Sinovent is a global biopharmaceutical company focused on innovation. Sinovent is centered around global standard excellence through its advanced biotechnology platform, decades of management experience, as …See details»
Shanghai Sinovent Biopharmaceutical Co., Ltd - Patsnap
Nov 8, 2024 Founded in 2017, Shanghai Sinovent Biopharmaceutical Co., Ltd. is a biopharmaceutical enterprise that integrates scientific research prowess with commercialization expertise to form a platform-based model for novel drug …See details»
Sinovent, Inc. - Overview, News & Similar companies - ZoomInfo
Aug 26, 2020 View Sinovent, Inc. (www.sinovent.com.cn) location in China , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
Sinovent Inc Company Profile 2024: Valuation, Funding
What industry is Sinovent Inc in? Sinovent Inc’s primary industry is Drug Discovery. Is Sinovent Inc a private or public company? Sinovent Inc is a Private company. What is Sinovent Inc’s …See details»
SinoMab, Sinovent and Everest Medicines Announce Licensing …
Sep 17, 2021 Sinovent is a global biopharmaceutical company focused on discovery, development, and commercialization of innovative medicines to address significant unmet …See details»
Sinovent - VentureRadar
Sinovent is a clinical stage biologics company that has 12 biologic products in development, four in clinical trials and another four molecules preparing to file INDs in China. Sinovent's lead …See details»
Everest Medicines, Sinovent and SinoMab Announce Licensing …
Sep 16, 2021 About Sinovent. Sinovent is a global biopharmaceutical company focused on discovery, development, and commercialization of innovative medicines to address significant …See details»
Sinovant Sciences - Crunchbase Company Profile & Funding
Sinovant Sciences is an innovative biopharmaceutical company based in Shanghai, Beijing and Hong Kong. Sinovant was founded by Chinese scientists and physicians, including Chinese …See details»
Sinovent - Funding, Financials, Valuation & Investors - Crunchbase
Sinovent is engaged in the technical development, consulting, and services of biological medicines. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much …See details»
Innovent
Oct 29 th, 2024. Innovent Announces Results of a Phase 2 Study of Picankibart (Anti-IL-23p19 Antibody) in Plaque Psoriasis, Showing Robust Efficacy in Patients with Prior Inadequate …See details»
Everest Medicines, Sinovent and SinoMab Announce Licensing …
Sep 17, 2021 Sinovent is a global biopharmaceutical company focused on discovery, development, and commercialization of innovative medicines to address significant unmet …See details»
SINOVENT PHARMACEUTICALS Revenue, Growth & Competitor …
Jan 8, 2024 Determine whether Sinovent Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. …See details»
XNW-28012 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 [Translation] An open-label, multicenter Phase I/II clinical study evaluating the safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of XNW28012 in …See details»
SinoMab, Sinovent and Everest Medicines Announce Licensing …
HONG KONG, Sept 17, 2021 - (ACN Newswire) - - SinoMab BioScience Limited (HKEX 3681.HK, "SinoMab") announced with Suzhou Sinovent Pharmaceuticals Co., Ltd. ("Sinovent") today …See details»
Sinovent - Updates, News, Events, Signals & Triggers - Crunchbase
Aug 25, 2020 DealStreetAsia — Chinese biopharma startup Sinovent closes $145m Series C round Funding Round • Aug 25, 2020 Sinovent raised CN¥1,000,000,000 / Series C from CCB …See details»
Invest In Sinovent Stock | Buy Pre-IPO Shares | EquityZen
Aug 28, 2020 Founded in 2016, Sinovent is a global biopharmaceutical company focused on innovation. Sinovent is centered around global standard excellence through its advanced …See details»
Sinovent - Crunchbase
Sinovent is engaged in the technical development, consulting, and services of biological medicines.See details»
XNW-27011 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 Phase I (dose escalation phase) Determine the maximum tolerated dose (MTD) and/or recommended dose (RP2D) of XNW27011. Phase II (dose expansion phase) Evaluate …See details»
Sinovent - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Sinovent . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Number of Board Member and Advisor …See details»
Sinovent - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Jul 15, 2024 Organization. Sinovent . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 1. Monthly …See details»